drugset / Trial / NCT05866679
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
NaSingle-groupOpen-labelDiagnostic
Summary
To learn if an MRSI can be performed on a 3T scanner using an investigational contrast drug called hyperpolarized 13-C pyruvate. 3T refers to the "strength" of the MRI machine.
Timeline
- Start
- 2024-04-12
- Primary completion
- 2026-08-31
- Completion
- 2028-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyperpolarized 13C-Pyruvate | Diagnostic / imaging agent | — | Oral |